$RLFTF (opinion) by icebear on Yh0 - Good Morning
Post# of 653
(Total Views: 264)
Posted On: 05/27/2021 3:21:51 AM
$RLFTF (opinion) by icebear on Yh0 - Good Morning All!
Excellent news with the AGM, they are doing the right thing and as a registered shareholder I'll look forward to it. We are on the right track:
.Zurich (awp) - On June 18, Relief Therapeutics will ask its shareholders to approve an increase in its authorized and conditional capital at an ordinary general meeting. The authorized capital is to be increased by half through the issue of 1.125 billion shares with a par value of 1 cent.
The increase of the conditional capital is to involve a maximum of 253.3 million shares, also with a nominal value of 1 cent. The two proposed transactions are intended to provide Relief with flexibility in financing future projects and strategic opportunities, according to the invitation to the annual conclave issued Thursday.
The meeting will also be asked to elect two new members to the board of directors, namely the head of the life sciences segment of New York law firm Hughes Hubbard & Reed, Patrice Jean, and the managing director of Ticino-based Applied Pharma Research, in accordance with the terms of the takeover agreement on the latter concluded in early May.
Chairman Raghuram Selvaraju and the sole remaining member Thomas Plitz will be standing for re-election.
Excellent news with the AGM, they are doing the right thing and as a registered shareholder I'll look forward to it. We are on the right track:
.Zurich (awp) - On June 18, Relief Therapeutics will ask its shareholders to approve an increase in its authorized and conditional capital at an ordinary general meeting. The authorized capital is to be increased by half through the issue of 1.125 billion shares with a par value of 1 cent.
The increase of the conditional capital is to involve a maximum of 253.3 million shares, also with a nominal value of 1 cent. The two proposed transactions are intended to provide Relief with flexibility in financing future projects and strategic opportunities, according to the invitation to the annual conclave issued Thursday.
The meeting will also be asked to elect two new members to the board of directors, namely the head of the life sciences segment of New York law firm Hughes Hubbard & Reed, Patrice Jean, and the managing director of Ticino-based Applied Pharma Research, in accordance with the terms of the takeover agreement on the latter concluded in early May.
Chairman Raghuram Selvaraju and the sole remaining member Thomas Plitz will be standing for re-election.
(0)
(0)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ